Preliminary Approach to Implementing a COVID-19 Thoracic Radiation Therapy Program.
other
Where this comes from
- Record sourced from PubMed, PMID 35123063.
- Also identified by DOI 10.1016/j.prro.2021.12.014 and PMC identifier 8808431.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The value of low-dose whole thoracic radiation therapy (LD-WTRT) for SARS-CoV-2 (COVID-19) pneumonia is unknown. Should ongoing clinical trials demonstrate that LD-WTRT proves effective for COVID-19 pneumonia recovery, widespread rapid implementation will be helpful globally. Our aim was to outline a pragmatic process for safe and efficient administration of LD-WTRT to patients with COVID-19 pneumonia that could be implemented successfully in a community hospital setting based on participation in the PreVent clinical trial of LD-WTRT.
Medical subject headings
- COVID-19